UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 20, 2020 4:01 P.M.

Form:	S-1
CIK: 0001815442 Company Name: Kymera Therapeutics, Inc. File Number: 333-240264